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Tuesday, February 23, 2010 497amouse sperm by a cAMP/PKA-mediated pathway with a pharmacological pro-
file suggestive of a Slc29a (ENT) equilibrative nucleoside transporter. Using
qRT-PCR we find in adult mouse testis 160- and 32-fold greater expression of
Slc29a1 than of the other surface-membrane ENT transporters Slc29a4 and
Slc29a2.However, Slc29a1 proteinwas not found onmature sperm using immu-
nocytochemistry. Moreover, wildtype and Slc29a1-null mice accelerate at sim-
ilar rates (1.5-2.0 Hz min1) in response to Cl-dAdo indicating that Slc29a1 is
not required for Cl-dAdo action. Consistent with this observation, the accelerat-
ing action of Cl-dAdo resists the Slc29a-selective inhibitor nitrobenzylthioino-
sine (NBTI; 10 mM). The accelerating action of Cl-dAdo additionally resists
replacement of external Naþwith NMDGþ indicating that Slc28a concentrative
nucleoside transporters (CNTs) also are not required. Interestingly, the Adeno-
sineA3 receptor-selective agonist Cl-IB-MECA (25mM) is nearly as effective as
Cl-dAdo in accelerating sperm beat frequency, suggesting a possible role for cell
surface A3 receptors in Cl-dAdo-mediated increases in sperm motility. Two A3
isoforms are expressed in the mouse Adora3i1 and Adora3i2; Adora3i2 expres-
sion is testis specific. Adora3i1 null sperm increase beat frequency in response to
both Cl-IB-MECA (25 mM) and Cl-dAdo (25 mM), so this isoform is not needed
for sperm response to adenosine. Sperm response to Cl-dAdo and Cl-IB-MECA
is diminished after pertussis toxin treatment of cells suggesting the receptor is
Gai/o coupled. We are currently testing functionality of the testis-specific novel
Adora3i2 isoform in a heterologous system. Support from U54-HD12629 of the
SCCPRR program of NICHD. L.A.B. supported in part by 5-T32-HD007453.
2576-Pos
Novel Receptor-Mediated Endothelial Cell Chemotaxis
Amir Shamloo, Frank Kuhnert, Vir Choksi, Calvin Kuo, Sarah Heilshorn.
Stanford University, Stanford, CA, USA.
The directed migration of endothelial cells away from existing blood vessels is
a critical step during cancer progression. Specific receptor-ligand interactions
initiate intracellular signal transduction pathways and asymmetric cytoskeletal
reorganization, leading to migration towards ligand sources. Disruption of these
receptor-ligand interactions is a common goal in cancer drug development, and
a key hurdle is the discovery of new receptor-ligand partners that are suitable tar-
gets. The G-protein-coupled receptor 124 (GPR124) is enriched in the endothe-
lium of the developing brain and regulates embryonic CNS angiogenesis; how-
ever, its ligand and its potential role in endothelial cell chemotaxis are unknown.
We examined the migration of mouse brain-derived endothelial cells (bEnd3)
within custom microfluidic devices capable of generating stable concentration
gradients of chemotactic ligands. The bEnd3 were genetically modified either
to overexpress (GPR124þ) or knock down (GPR124-) receptor expression.
GPR124þ cells were observed to chemotax in response to a 0.025% gradient/
micron of embryonic brain cortical cell conditioned medium (CM), while
GPR124- cells followed randomwalk statistics in identical gradients.Mathemat-
ical analysis of the cell migration pathways (n~100 for each condition) revealed
that netmigration displacement,migration persistence time, andmigration speed
were increased for GPR124þ cells over GPR124- cells in both CM gradients as
well as uniformCMconcentrations. This suggests that in addition to being able to
initiate asymmetric cytoskeletal reorganization, GPR124 signaling also triggers
a general enhancement in cell motility. GPR124þ cells were also found to mi-
grate towards VEGF-depleted CM, demonstrating that GPR124-mediated che-
motaxis is independent from VEGF-mediated chemotaxis, a widely studied li-
gand of endothelial cells and a common cancer drug target. GPR124þ cells
did not chemotax towards CM of 193T cells, a negative control kidney cell
line.These results demonstrate utility of a newquantitativemicrofluidic platform
to identify novel receptor-ligand partners for potential cancer drug development.
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The interaction of G-protein-coupled receptors with G proteins is a key event in
transmembrane signal transduction leading to vital decision-taking of the cell.
Here we applied single-molecule epifluorescence microscopy to study the mo-
bility of both the Gbg and the Ga2 subunits of the G protein heterotrimer in
comparison to the cAMP-receptor responsible for chemotactic signaling in Dic-
tyostelium discoideum. Our experimental results suggest that ~30% of the
G protein heterotrimers exist in receptor pre-coupled complexes. Upon stimu-
lation in a chemotactic gradient this complex dissociates, subsequently leading
to a linear diffusion/collision amplification of the external signal. The further
observation of partial immobilization and confinement of Gbg in an agonist,
F-actin and Ga2-dependent fashion led to the hypothesis of functional nano-
metric domains in the plasma membrane that locally restrict the activation sig-
nal and in turn lead to faithful and efficient chemotactic signaling.2578-Pos
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The physical properties of substrates are known to control cell adhesion via in-
tegrin-mediated signaling. Recently, we have shown that binding of fibrinogen
to the surface of fibrin gel prevents integrin aMb2-mediated leukocyte adhesion
by creating an anti-adhesive layer. Furthermore, fibrinogen immobilized on
various surfaces at high density supports weak cell adhesion whereas at low
density it is highly adhesive.
To gain an understanding of the mechanism underlying differential cell adhe-
sion, we extended the cell adhesion assays to platelets carrying integrin aIIbb3.
The results showed a similar behavior indicating that the process is independent
of the type of integrins. In order to quantify the adhesion forces, we applied sin-
gle cell force spectroscopy (SCFS). In this assay, a single cell is attached to
a tipless cantilever of an atomic force microscope (AFM) and force-distance
curves for different surfaces are acquired. For cells carrying aMb2-integrins
we found significant lower adhesion forces for high- compared to low-density
fibrinogen substrates.
Furthermore, we analyzed the adhesive behavior of fibrinogen surfaces using
force spectroscopy with a silicon nitride AFM tip. These experiments, unrelated
to the cells and integrins, show similar behaviors as the cell adhesion assays.
AFM images of the different substrates indicate that fibrinogen deposition at
high density results in an aggregated multilayered material characterized by
low adhesion forces. However, low-density fibrinogen produces a single layer
in which molecules are directly attached to the solid surface resulting in higher
adhesion forces.
The data suggest that deposition of a multilayered fibrinogen matrix prevents
stable cell adhesion by modifying the physical properties of surfaces resulting
in reduced force generation with implications for hemostasis and biomaterial
applications.
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Kidney glomeruli function as filters, allowing the passage of small solutes and
waste products into the urinary space, while retaining essential proteins and
macromolecules in the blood stream. They achieve this through a filtration ap-
paratus comprised of three layers, a fenestrated glomerular endothelium, a base-
ment membrane (GBM) and an epithelial cell layer. Glomerular epithelial cells
(podocytes) culminate into interdigitating foot processes (FPs) between adja-
cent cells. Specialized structures known as slit diaphragms (SDs) function as
modified adherens junctions connecting podocyte foot processes. These struc-
tures are under constant mechanical stress due to fluid pressure, driving filtra-
tion across the barrier. Disruption of the SDs or podocyte damage can lead to
progressive loss of protein into the urine (proteinuria) and ultimately to kidney
failure. Dysregulation of the podocyte actin cytoskeleton has been implicated in
mechanisms of proteinuria.
Podocyte adhesion on collagen activates the FAK/ERK pathway, a known me-
diator of F-actin assembly. Here, we mechanically stimulated adherent podo-
cytes using a cell stretcher. A 20% strain at 1 Hz for 20 min increased ERK
phosphorylation compared to control. We observed a peak after 2 min and
thereafter an exponential decrease. This suggests that podocytes are responsive
to early external strain, which might be transduced into a chemical signal capa-
ble of modulating the actin cytoskeleton. We hypothesize that adhesion via in-
tegrin receptors triggers mechanochemical signals which may in turn affect
cell-cell and cell-GBM connections. Currently, we are studying the effects of
cytoskeletal organization/regulation in wildtype and mutated podocytes, with
a focus on determining cell mechanical properties using magnetic tweezers
and atomic force microscopy.
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Atherosclerosis is a progressive disease characterized in particular by the accu-
mulation of lipids and fibrous elements in arteries. Over the past decade,
498a Tuesday, February 23, 2010scientists come to appreciate a prominent role for inflammation in atheroscle-
rosis. This work is devoted to the construction of a model of formation of
lesions of earliest type arising in atherosclerosis. We consider that the inflam-
matory process starts with the penetration of Low Density. Lipoproteins choles-
terol in the intima. This phenomenon is related to the local blood flow dynam-
ics. The blood flow is simulated by the Navier-Stokes equations, together with
the continuity equation. LDL transport in lumen of the vessel is modelled with
convective-diffusion equation, and inflammatory process is solved with three
additional reaction-diffusion partial differential equations. The plaque growing
is modeled by Stokes equation [1], [2] and [3]. The input data for the flow
waveforms are taken fromMR phase contrast flowmeasurements of the patient.
The computed results show velocity profiles, shear stress distribution and LDL
distribution in blood lumen [2] and [3]. Computed concentration oxidized LDL,
macrophages and cytokines indicate that there is a newly formed matter in the
intima, especially in the flow separation region of LAD during most of the di-
astole. In summary, full model of plaque formation and development, coupled
with blood flow and LDL concentration in blood, is created.
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Signaling by the erbB family of transmembrane tyrosine kinase receptors con-
trols many cellular pathways, including growth and differentiation, while dys-
regulation of erbB signaling is a hallmark of many cancers. To understand how
receptor interactions regulate signaling, we have developed new multi-color
single molecule tracking and analysis techniques. Diffusion and dimerization
of erbB1 receptors on live cells were monitored with single particle tracking
by using antibody fragments or ligand probes coupled to quantum dots
(QDs). As a probe for resting receptors, we used a non-activating, non-compet-
ing, monovalent fragment of an anti-erbB1 heavy-chain only antibody (VhH).
To track activated receptors, QDs conjugated to EGF ligand were employed.
Dimer lifetimes were determined from two-color single particle trajectories us-
ing a modified Diffusive HiddenMarkovModel. This analytic two-state (bound
and free) model uses the two-color QD trajectories to find bound states and
quantify the dimerization lifetime using a global estimation over many trajec-
tories. We capture the behavior of erbB1 receptors diffusing on the surface of
live A431 cells, including the formation of long-lived dimers between two
EGF-QD-erbB1 complexes. Treatment with PD153035, a specific inhibitor
of erbB1 tyrosine kinase activity, increases receptor diffusion rate and reduces
the lifetime of erbB1 homodimers, suggesting a role for the active kinase do-
main in formation of stable dimers. These results demonstrate the capabilities
of innovative imaging and analysis approaches to measure protein-protein
interaction kinetics in real time.
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Understanding how specific proteins are recruited tomembranes is crucial to un-
derstanding key biological functions. Membrane curvature sensing is increas-
ingly recognized as a powerful means for guiding protein localization, coupling
protein binding to the local membrane geometry. The mechanisms underlying
curvature sensing remain poorly quantified, however. We focus on the two cur-
vature-associated proteins that share an amphipathic alpha-helical structure. The
first, SpoVM, is a small (26 residue) protein from Bacillus subtillus that has re-
cently been shown to preferentially bind to convex surfaces [K.S. Ramamurthy
et al., Science 323: 1354 (2009)]. The second is the 23 amino acid N-terminal
helical domain of Sar1, which initiates the assembly of COPII coated vesicles
at the endoplasmic reticulum and which recent work [Parthasarthy Lab, unpub-
lished] has shown to dramatically altermembrane rigidity. Using bothmicrofab-
ricated surfaces that present controlled curvatures to the proteins and optical-trap
based assays involving dynamic membrane deformation, we quantify the curva-
ture dependence of the membrane binding affinity of these structurally similar
yet functionally disparate proteins.
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Intracellular cargo trafficking involves dramatic changes in membrane shape,
the mechanics of which remain poorly understood. We focus on Sar1, the
key regulator of the coat protein complex II (COPII) family that ferries newly
synthesized proteins from the endoplasmic reticulum (ER), and the only mem-
ber of the COPII coat that interacts directly with the ER lipid bilayer mem-
brane. To investigate whether Sar1 has a role beyond merely localizing the
other COPII proteins, we directly measure the force involved in membrane
deformation as a function of its concentration, using optically trapped micro-
spheres to pull tethers from in vitro lipid membranes whose composition and
large surface area mimic the composition and geometry of the ER. We find
that Sar1 lowers the rigidity (bending
modulus) of lipid membranes to
nearly zero in a concentration-depen-
dent manner. Moreover, Sar1 lacking
its N-terminal amphipathic helix in-
duces negative (concave) spontane-
ous membrane curvature. These re-
sults reveal a paradigm-altering
insight into COPII trafficking: Sar1
actively alters the material properties
of the membranes it binds to, lower-
ing the energetic cost of curvature
generation.
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Targeting of newly synthesized membrane proteins to the endoplasmic reticu-
lum is an essential cellular process. Most membrane proteins are recognized
and targeted co-translationally by the signal recognition particle. However,
nearly 5% of membrane proteins are ‘tail-anchored’ (TA) by a single C-termi-
nal transmembrane domain that cannot access the co-translational pathway.
Instead, TA proteins are targeted post-translationally by a conserved ATPase
termed Get3. The mechanistic basis for TA protein recognition or targeting
by Get3 is not known. Here we present crystal structures of Get3 in ’open’
(nucleotide-free) and ‘closed’ (ADPAlF4–bound) dimer states. In the closed
state, the dimer interface of Get3 contains an enormous hydrophobic groove
implicated by mutational analyses in TA protein binding. In the open state,
Get3 undergoes a dramatic rearrangement that disrupts the groove and shields
its hydrophobic surfaces. These data provide a molecular mechanism for nucle-
otide-regulated binding and release of TA proteins during their membrane
targeting by Get3.
